Associated Papers
Generation of CRISPR/Cas9 modified human iPSC line with correction of heterozygous mutation in exon 6 of the CaSR gene.
Semenova PI et al.
Human Cell, 2024
Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene.
Panova AV et al.
Stem Cell Research, 2021
Select a paper to view details